Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada | Synapse
March 3, 2026
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada
Key Points
Clinical outcomes of first line treatment for advanced renal cell carcinoma vary significantly in older patients, showing notable responses to therapy.
Among older patients receiving treatment, the response rate observed was approximately 45%, underlining the potential benefits of timely intervention.
The analysis focused on real-world management of advanced renal cell carcinoma, comparing treatment approaches across various healthcare settings in Canada.
Findings highlight the importance of tailored approaches for older patients, advocating for further studies on the effectiveness of specific treatment protocols.